Fig. 2From: BH3-mimetics: recent developments in cancer therapyThe regulation of apoptosis by the BAX protein through mitochondrial outer membrane permeabilization (MOMP), and the modulation of this key steps by therapeutics. Key negative regulator Bcl-2, Bcl-xL and Mcl1 proteins (solid oval green boxes) for BAX (solid orange box) and their apoptosis inducing effects by cytochrome c release (solid yellow box and circles), caspase protein activation (solid red box) and apoptosis (solid purple box) are shown. The mimetics/inhibitors that can target anti−/pro-apoptotic protein interactions are highlighted as BH3-mimetics (outlined red box, red dots) and Mcl1 inhibitors (outlined green box, green dots), which either induce apoptosis of cells as mono-therapeutics or sensitize them to such effects during combined therapeutic targeting. The blue solid boxes (and small circles) highlight mitochondrial Smac/DIABLO, NOXA and PUMA, which bind the Inhibitor of Apoptosis Proteins (small green circles, IAPs) and the interactions of which can be inhibited by Smac-mimetics (blue outlined box and blue dots)Back to article page